|
| 1 |
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257. Published online 2022 July 19
DOI: http://dx.doi.org/10.4143/crt.2022.232
|
|
| 2 |
Signature of arylacetamide deacetylase expression is associated with prognosis and immune infiltration in ovarian cancer
Jianyang Feng, Hong He
Obstet Gynecol Sci.2022;65(1):52-63. Published online 2022 January 15
DOI: http://dx.doi.org/10.5468/ogs.21237
|
|
| 3 |
The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Obstet Gynecol Sci.2021;64(5):444-453. Published online 2021 August 17
DOI: http://dx.doi.org/10.5468/ogs.21116
|
|
| 4 |
Practical issues and research trends of oncofertility in gynecologic cancer
Jeong-Yeol Park
|
|
| 5 |
Assessment of different NEoplasias in the adneXa model for differentiation of benign and malignant adnexal masses in Korean women
Gina Nam, Sa Ra Lee, Kyungah Jeong, Sung Hoon Kim, Hye-Sung Moon, Hee Dong Chae
Obstet Gynecol Sci.2021;64(3):293-299. Published online 2021 February 17
DOI: http://dx.doi.org/10.5468/ogs.21012
|
|
| 6 |
Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells
Hye-yon Cho, Yong-Beom Kim, Wook-ha Park, Jae Hong No
Cancer Res Treat.2021;53(3):819-828. Published online 2020 December 16
DOI: http://dx.doi.org/10.4143/crt.2020.1013
|
|
| 7 |
Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim
Cancer Res Treat.2021;53(2):541-548. Published online 2020 November 18
DOI: http://dx.doi.org/10.4143/crt.2020.1001
|
|
| 8 |
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.2020;52(4):1229-1241. Published online 2020 July 27
DOI: http://dx.doi.org/10.4143/crt.2020.557
|
|
| 9 |
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
Aiko Ogasawara, Taro Hihara, Daisuke Shintani, Akira Yabuno, Yuji Ikeda, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa
Cancer Res Treat.2020;52(4):1219-1228. Published online 2020 May 6
DOI: http://dx.doi.org/10.4143/crt.2019.688
|
|
| 10 |
Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
Young Shin Chung, Hyun-Soo Kim, Jung-Yun Lee, Won Jun Kang, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
Cancer Res Treat.2020;52(4):1211-1218. Published online 2020 April 28
DOI: http://dx.doi.org/10.4143/crt.2019.506
|
|
| 11 |
G Protein–Coupled Receptor 30 Mediates the Anticancer Effects Induced by Eicosapentaenoic Acid in Ovarian Cancer Cells
Yue Zhao, Meng-Fei Zhao, Mei-Lin Yang, Tian-Yu Wu, Cong-Jian Xu, Jing-Mei Wang, Chao-Jun Li, Xi Li
Cancer Res Treat.2020;52(3):815-829. Published online 2020 March 5
DOI: http://dx.doi.org/10.4143/crt.2019.380
|
|
| 12 |
Clinical and histopathologic analysis of gynecological cancer: a single institute experience over 7 years
Soo-Young Lee, Eunbyeol Kim, Hyo-Shin Kim, Yu-Jin Koo, Dae-Hyung Lee
|
|
| 13 |
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
Mi-Ryung Han, Sug Hyung Lee, Jung Yoon Park, Hyosun Hong, Jung Yoon Ho, Soo Young Hur, Youn Jin Choi
Cancer Res Treat.2020;52(3):779-788. Published online 2020 February 28
DOI: http://dx.doi.org/10.4143/crt.2019.700
|
|
| 14 |
Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
Min Ae Cho, Soo Young Jeong, Insuk Sohn, Myeong-Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Chel Hun Choi
Cancer Res Treat.2020;52(2):645-654. Published online 2020 January 16
DOI: http://dx.doi.org/10.4143/crt.2019.509
|
|
| 15 |
Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely
Kyoko Nishikimi, Shinichi Tate, Kazuyoshi Kato, Ayumu Matsuoka, Makio Shozu
|
|
| 16 |
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
Masato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka Kikkawa
|
|
| 17 |
Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
Hyejeong Hue, Kidong Kim, HyoJin Kim, Dong Hoon Suh, Jae Hong No, Yong Beom Kim
|
|
| 18 |
Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis
Hongyan Cheng, Lanqing Huo, Dan Wang, Yang Xiang
|
|
| 19 |
The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
Ga Won Yim, Dong Hoon Suh, Jae-Weon Kim, Seung Cheol Kim, Young Tae Kim
|
|
| 20 |
Is Second Look Laparoscopy for Diagnosing Remaining Ovarian Cancer Appropriate Further Treatment?
Rama Inamdar, Ahyoung Cho, Hae Kyung Yoo, Hye-Sung Moon
Ewha Med J.2019;42(2):15-19. Published online 2019 April 29
DOI: http://dx.doi.org/10.12771/emj.2019.42.2.15
|
|
